Reported Jul 26, 2023 · Terminated
Famotidine Tablets, USP, 20mg, 200-count bottle within a carton, Distributed by: Glenmark Therapeutics Inc., USA,…
Glenmark Therapeutics, Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Glenmark Therapeutics, Inc. · 750 Corporate Dr · Mahwah, NJ · 07430-2009
Is this the product you have?
- Famotidine Tablets, USP, 20mg, 200-count bottle within a carton
- Distributed byGlenmark Therapeutics Inc., USA, Mahwah, NJ 07430, Made in India, NDC 72657-113-20
- Lot codes and dates
FA2022001BExp 03/2025
- Amount recalled
- 19,968 bottles
Where it was sold
- Nationwide
Why it was recalled
Labeling: Label Error on Declared Strength: some cartons labeled and containing 20 mg may have an external label placed on the side of the carton indicating strength as 10 mg.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Glenmark Therapeutics, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.